Stereotactic Body Radiotherapy for Medically Inoperable Stage I-II Non-Small Cell Lung Cancer: The Mayo Clinic Experience.

Corey J Hobbs,Stephen J Ko,Nitesh N Paryani,Joseph M Accurso,Kenneth R Olivier,Yolanda I Garces,Sean S Park,Christopher L Hallemeier,Steven E Schild,Sujay A Vora,Jonathan B Ashman,William G Rule, Johnny R Bowers,Michael G Heckman,Nancy N Diehl,Robert C Miller

Mayo Clinic Proceedings: Innovations, Quality & Outcomes（2018）

引用 20|浏览31

暂无评分

摘要

Disease control was excellent for patients who received SBRT for early-stage NSCLC, and this series represents the largest single-institution experience from the United States on SBRT for early-stage inoperable NSCLC. Higher pretreatment FDG-PET SUVmax was associated with increased risk of any recurrence, and the 50 Gy in 5 fractions dose prescription was associated with increased risk of local recurrence.

查看译文

关键词

BED,CT,DFS,EBUS,FDG-PET,HR,ITV,LC,NSCLC,OS,PET,RTOG,SBRT,SUVmax

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要